The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Remarkable increase in the concentration of 8-hydroxyguanosine in cerebrospinal fluid from patients with Alzheimer’s disease
Open accessAbstract
To investigate the possible role of oxidative RNA damage in the pathogenesis of Alzheimer's disease (AD), the concentrations of the oxidative stress marker 8-hydroxyguanosine (8-OHG) were measured in the cerebrospinal fluid (CSF) and the serum of patients with AD and control subjects. The concentration of 8-OHG in CSF in AD patients was approximately fivefold that in controls (P < 0.001). The concentration of 8-OHG in CSF decreased significantly with the duration of illness (r(s) = -0.48, P < 0.05) and the progression of cognitive dysfunctions (r(s) = 0.67, P < 0.01). However, the concentration of 8-OHG in CSF showed no correlation with that in serum in both the controls and AD patients. In addition, the concentration of 8-OHG in serum was not significantly altered in AD patients compared to that in controls, suggesting that the 8-OHG concentrations in the CSF do not reflect those in serum and may be probably reflect those in brain tissue. These in vivo findings suggest a possible role of 8-OHG and increased oxidative RNA damage in the early stage of the development of AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Oxidation of DNA and RNA produced by ROS also occurs in AD [50,51,52,53].”
From Role of Oxidative Damage in Alzheimer’s Disease and Neurodegeneration: From Pathogenic Mechanisms to Biomarker Discovery (2021) · cites this paper as [52]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
American Psychiatric Association (2013) · doi:10.1176/appi.books.9780890425596 · Cited by 116,369
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Aging: a theory based on free radical and radiation chemistry
Harman, D. (1956) · Journal of Gerontology · doi:10.1093/geronj/11.3.298 · Cited by 8,567
Diagnostic and Statistical Manual of Mental Disorders, 5th Edition
(2013) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9780890425596.893619 · Cited by 4,412
. Cerebral blood flow in dementia.
Hachinski, V. C., Iliff, L. D., Zilhka, E., Du Boulay, G. H., McAllister, V. L., Marshall, J., Russell, R. W. R., & Symon, L. (1975) · Archives of Neurology · doi:10.1001/archneur.1975.00490510088009 · Cited by 3,186
Hydrogen peroxide mediates amyloid β protein toxicity
Behl, C. (1994) · Cell · doi:10.1016/0092-8674(94)90131-7 · Cited by 2,074
Oxidative Damage Is the Earliest Event in Alzheimer Disease
Nunomura, A., Perry, G., Aliev, G., Hirai, K., Takeda, A., Balraj, E. K., Jones, P. K., Ghanbari, H., Wataya, T., Shimohama, S., et al. (2001) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/60.8.759 · Cited by 1,885
Aging, energy, and oxidative stress in neurodegenerative diseases
Beal, M. F. (1995) · Annals of Neurology · doi:10.1002/ana.410380304 · Cited by 1,434
Widespread Peroxynitrite-Mediated Damage in Alzheimer’s Disease
Smith, M. A., Richey Harris, P. L., Sayre, L. M., Beckman, J. S., & Perry, G. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-08-02653.1997 · Cited by 1,239
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–124 of 124
Puentes‐Díaz, N., Chaparro, D., Morales‐Morales, D., Alí‐Torres, J., & Flores‐Gaspar, A. (2023) · ChemPlusChem · doi:10.1002/cplu.202300405 · Cited by 4
Role of DDX1 in the oxidative response of ataxia telangiectasia patient-derived fibroblasts
Garg, M., Li, L., & Godbout, R. (2023) · Redox Biology · doi:10.1016/j.redox.2023.102988 · Cited by 4
Prospects for Antioxidant Therapy in Mild Cognitive Impairment and Alzheimer's Disease
Nunomura, A., Perry, G. L., & Smith, M. A. (2007) · Elsevier eBooks · doi:10.1016/b978-044452809-4/50161-7 · Cited by 4
Mechanisms and targeted treatments of cobalt-encephalopathy from cobalt-chromium orthopedic implants
Wu, T., Li, H., & Chen, W. (2025) · Neuroscience · doi:10.1016/j.neuroscience.2025.08.008 · Cited by 3
Role of a Urinary Biomarker in the Common Mechanism of Physical Performance and Cognitive Function
Jiang, S., Cui, J., Zhang, L., Liu, Z. Q., Zhang, Y., Shi, Y. L. Z., & Cai, J. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.816822 · Cited by 3
Singh, A. K., Rana, H. K., & Pandey, A. K. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-819096-8.00012-4 · Cited by 3
Epitranscriptional Regulation: From the Perspectives of Cardiovascular Bioengineering
Chen, Z., He, M., Li, J. Y.-S., Shyy, J. Y.-J., & Chien, S. (2023) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-081922-021233 · Cited by 3
An update on pathological implications of enzymatic dysregulation in Alzheimer's disease
Choudhury, A., Chakraborty, I., Bhattacharjee, R., Banerjee, T. S., Vana, D. R., Adapa, D., & Bhardwaj, R. (2018) · Biomedical Research - India · doi:10.4066/biomedicalresearch.29-18-767 · Cited by 3
Neurodegenerative disease and the repair of oxidatively damaged DNA
Cooke, M. S. (2005) · Cambridge University Press eBooks · doi:10.1017/cbo9780511544873.011 · Cited by 4
Cerebrospinal fluid biomarkers for neurodegenerative disorders
Videira, R. M. A. S. (2013) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · Cited by 2
Role of Oxidative Insult and Neuronal Survival in Alzheimer’s and Parkinson’s Diseases
Nunomura, A., Moreira, P. I., Zhu, X., Cash, A., Smith, M. A., & Perry, G. L. (2007) · Springer eBooks · doi:10.1007/978-0-387-72076-0_14 · Cited by 2
Properties, Molecular Effects and Signalling Pathways of Reactive Oxygen Species
Anbumani, D., Dhandapani, K. V., & Ranganathan, B. (2026) · Springer eBooks · doi:10.1007/978-981-95-3758-7_14 · Cited by 1
Osei, G. N., Kpelle, L., Appiah, F., Nartey, K., Adu, A. O., Simpong, D. L., & Afrifa, J. (2026) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.70354 · Cited by 1
Oxidative Stress and Neuropsychiatric Disorders in the Life Spectrum
Nunomura, A., Tamaoki, T., Motohashi, N., Lee, H., Zhu, X., & Perry, G. L. (2016) · CRC Press eBooks · doi:10.1201/b20228-16 · Cited by 1
Contribution of Nucleic Acids in the Pathogenesis of Alzheimer’s Disease
Farooqui, A. A. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809937-7.00004-5 · Cited by 1
Κούκα, Π. (2020) · doi:10.12681/eadd/47951 · Cited by 1
Biological Markers in Alzheimer's Disease
Diaz-Arrastia, R. R., & Baskin, F. (2003) · Humana Press eBooks · doi:10.1007/978-1-59259-661-4_10 · Cited by 1
The novel role of the neuropeptides orexin and QRFP and their involvement in Alzheimer's disease
Davies, J. (2014) · Brunel University Research Archive (BURA) (Brunel University London)
Wu, J., & Wu, J. (2008) · ProQuest Demo Repository
Temporal Primacy of Oxidative Stress in the Pathological Cascade of Alzheimer Disease
Tabata, K., Nunomura, A., Chiba, S., Perry, G. L., & Smith, M. A. (2005) · Oxidative stress and disease · doi:10.1201/9781420026559.ch21
Oxidative Stress and Neuropsychiatric Disorders in the Life Spectrum
Ahmad, S. I. (2016) · CRC Press eBooks · doi:10.1201/b20228-23
Qiao, N., Liu, Y., Qiao, S., Li, H., Ma, Q., & Guo, S. (2025) · Analytical Chemistry · doi:10.1021/acs.analchem.5c05618
Newman, S. F. (2009) · UKnowledge (University of Kentucky)
Metadata
- Authors
- Abe, T., Tohgi, H., Isobe, C., Murata, T., & Sato, C.
- Affiliations
- Iwate Medical University (JP)
- Corresponding author
- Tohgi, Hideo
- ORCID
- Abe, Takashi
- Venue
- Journal of Neuroscience Research
- Publisher
- Wiley
- Published
- 2002-10-18
- Volume
- 70
- Issue
- 3
- Pages
- 447-450
- ISSN
- 0360-4012 (ISSN-L)
- 1097-4547
- OpenAlex
- W2059334739
- Cited by
- 124
- References
- 32
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 5 · 2023: 7 · 2022: 8 · 2021: 5 · 2020: 7 · 2019: 4 · 2018: 3 · 2017: 6 · 2016: 6 · 2015: 4 · 2014: 6 · 2013: 5 · 2012: 9
- FWCI
- 1.80
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Neuroscience Research (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Biochemistry (medical) › Antioxidant Activity and Oxidative Stress
- Keywords
- 8-hydroxyguanosine, Alzheimer's disease, cerebrospinal fluid biomarkers, oxidative RNA damage, oxidative stress, serum biomarkers, disease progression, cognitive decline
- MeSH terms
- Aged, Alzheimer Disease, Brain, Female, Guanosine, Humans, Male, Middle Aged, Neurons, RNA, Up-Regulation, Oxidative Stress
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
